| 注册
首页|期刊导航|中国中药杂志|丹酚酸B对冠状动脉粥样硬化性心脏病的作用机制研究进展

丹酚酸B对冠状动脉粥样硬化性心脏病的作用机制研究进展

曹洪鸣 孙晖 刘畅 闫广利 孔玲 韩莹 王喜军

中国中药杂志2025,Vol.50Issue(6):1449-1457,9.
中国中药杂志2025,Vol.50Issue(6):1449-1457,9.DOI:10.19540/j.cnki.cjcmm.20241213.601

丹酚酸B对冠状动脉粥样硬化性心脏病的作用机制研究进展

Research advances in mechanism of salvianolic acid B in treating coronary heart disease

曹洪鸣 1孙晖 1刘畅 1闫广利 1孔玲 1韩莹 1王喜军1

作者信息

  • 1. 黑龙江中医药大学 经方与现代中药融合创新全国重点实验室 国家中医药管理局中医方证代谢组学研究中心,黑龙江 哈尔滨 150040
  • 折叠

摘要

Abstract

Coronary heart disease is a cardiovascular disease that affects coronary arteries.It presents high incidence and high mortality worldwide,bringing a serious threat to human health and quality of life.Salviae Miltiorrhizae Radix et Rhizoma derived from Salvia miltiorrhiza is widely used in the treatment of cardiovascular diseases,such as coronary heart disease.Salvianolic acid B is an active component in Salviae Miltiorrhizae Radix et Rhizoma extracts,and studies have shown that it has anti-inflammatory,antioxidant,apoptosis-and autophagy-regulating,anti-fibrosis,and metabolism-modulating effects.This article reviews the research progress regarding the therapeutic effect of salvianolic acid B on coronary heart disease in the recent decade.It elaborates on the role and mechanism of salvianolic acid B in treating coronary heart disease from multiple perspectives,such as the inhibition of thrombosis,improvement of blood circulation,reduction of myocardial cell injury,and inhibition of cardiac remodeling.This article provides a theoretical basis for the application of Chinese medicinal materials and TCM prescriptions containing salvianolic acid B in the treatment of coronary heart disease.

关键词

丹酚酸B/丹参/冠心病/血栓/心肌损伤

Key words

salvianolic acid B/Salviae Miltiorrhizae Radix et Rhizoma/coronary heart disease/thrombus/myocardial damage

引用本文复制引用

曹洪鸣,孙晖,刘畅,闫广利,孔玲,韩莹,王喜军..丹酚酸B对冠状动脉粥样硬化性心脏病的作用机制研究进展[J].中国中药杂志,2025,50(6):1449-1457,9.

基金项目

国家自然科学基金青年科学基金项目(82304709) (82304709)

中国中药杂志

OA北大核心

1001-5302

访问量0
|
下载量0
段落导航相关论文